Clonidine-displacing substance (CDS) and its putative imidazoline receptor. New leads for further divergence of alpha 2-adrenergic receptor activity.
about
Biological significance of agmatine, an endogenous ligand at imidazoline binding sitesImidazoleacetic acid-ribotide: An endogenous ligand that stimulates imidazol(in)e receptorsImidazoline recognition sites and stomach function.Imidazoleacetic acid-ribotide induces depression of synaptic responses in hippocampus through activation of imidazoline receptors.Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological functionImidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brainI2-imidazoline receptors in the healthy and pathologic human brain.In situ hybridization. A complementary method to radioligand-mediated autoradiography for localizing adrenergic, alpha-2 receptor-producing cells.Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine.Molecular and physiological properties of clonidine-displacing substance.Nonadrenergic imidazoline binding sites and amine oxidase activities in fat cells.Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.The relationship between the adrenoceptor and nonadrenoceptor-mediated effects of imidazoline- and imidazole-containing compounds.Clonidine and cirazoline inhibit activation of nicotinic channels in PC-12 cells.Imidazoleacetic acid-ribotide in vestibulo-sympathetic pathway neurons.Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats.Antagonism of levcromakalim by imidazoline- and guanidine-derivatives in rat portal vein: involvement of the delayed rectifier.The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.The effects of imidazoline agents on the aggregation of human platelets.
P2860
Q24673628-ADD3235D-C40A-47BA-B480-A6822D60160DQ30048258-CB3CC303-3FFA-4A3D-A614-DBDE4AB34A92Q33693067-0235D77F-F5AF-4001-87C4-AA486D8DF0FDQ34781103-C77ED0EC-6E2E-49E7-8677-5AE49F51F682Q35870529-49873AE8-BABE-43BE-8464-411147808224Q35870817-9DEAFA6C-F259-4F30-9D18-BDA5B81D1E13Q35871470-1043AEDD-FA25-440C-8C1F-474AA19BB381Q40483894-8D9C90AC-9253-4383-B905-7864548DD9A6Q40483905-221EF524-A07F-43F7-A92B-B28457D7A306Q40483933-F02D6354-687E-4915-BB1D-00DBC8BE81DAQ40483936-7FD51622-E954-49FA-B19F-5AE6C548F563Q40483957-A9F3D22E-AF8A-4067-AF22-1BBCE4257559Q40483987-F54DC447-CCE4-44AF-BC3F-7734328E4DB4Q40484002-D771D89F-DD7A-47C8-886C-A9695966F92EQ41326176-6B852D5B-B6B5-4BEC-9262-332D55880422Q41641431-7DB62703-7441-44F0-AB0D-85EB2F75CCC6Q41897504-C3CB668E-9563-4E26-A248-2FF5231ED7BDQ41934182-06CD8E2C-8CE5-48E9-B7C2-320479FD5F74Q41957971-1888D3F9-1052-4ED2-AF4E-D7E7FD8A68AAQ42069216-470DE276-B58F-4167-B000-D49F5C1E7851Q42701372-AB92884F-30C4-4EA1-817E-FE2A003329C6Q42715181-A18496C6-04AD-438C-B94F-D509EA28505DQ44789803-09CDB294-DA3E-42BC-B7EC-8C4C8E006B26
P2860
Clonidine-displacing substance (CDS) and its putative imidazoline receptor. New leads for further divergence of alpha 2-adrenergic receptor activity.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Clonidine-displacing substance ...... -adrenergic receptor activity.
@ast
Clonidine-displacing substance ...... -adrenergic receptor activity.
@en
type
label
Clonidine-displacing substance ...... -adrenergic receptor activity.
@ast
Clonidine-displacing substance ...... -adrenergic receptor activity.
@en
prefLabel
Clonidine-displacing substance ...... -adrenergic receptor activity.
@ast
Clonidine-displacing substance ...... -adrenergic receptor activity.
@en
P1476
Clonidine-displacing substance ...... -adrenergic receptor activity.
@en
P2093
P304
P356
10.1016/0006-2952(91)90152-U
P407
P577
1991-06-01T00:00:00Z